• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling.基于配体竞争饱和的位点识别(SILCS)辅助药效团建模。
J Comput Aided Mol Des. 2014 May;28(5):491-507. doi: 10.1007/s10822-014-9728-0. Epub 2014 Mar 8.
2
Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules.使用配体竞争饱和法(SILCS)结合多个探针分子进行药效团建模。
J Chem Inf Model. 2015 Feb 23;55(2):407-20. doi: 10.1021/ci500691p. Epub 2015 Feb 6.
3
Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations.利用配体竞争饱和的位点鉴定(SILCS)模拟重现配体官能团的晶体结合模式。
J Chem Inf Model. 2011 Apr 25;51(4):877-96. doi: 10.1021/ci100462t. Epub 2011 Apr 1.
4
Assessing hERG1 Blockade from Bayesian Machine-Learning-Optimized Site Identification by Ligand Competitive Saturation Simulations.基于配体竞争饱和模拟的贝叶斯机器学习优化靶点识别评估 hERG1 阻断作用。
J Chem Inf Model. 2020 Dec 28;60(12):6489-6501. doi: 10.1021/acs.jcim.0c01065. Epub 2020 Nov 16.
5
Computational fragment-based binding site identification by ligand competitive saturation.基于配体竞争饱和的计算性片段结合位点识别
PLoS Comput Biol. 2009 Jul;5(7):e1000435. doi: 10.1371/journal.pcbi.1000435. Epub 2009 Jul 10.
6
Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach.通过配体竞争饱和(SILCS)方法在位点识别中纳入多种片段类型。
J Chem Inf Model. 2013 Dec 23;53(12):3384-98. doi: 10.1021/ci4005628. Epub 2013 Nov 25.
7
Identification and characterization of fragment binding sites for allosteric ligand design using the site identification by ligand competitive saturation hotspots approach (SILCS-Hotspots).使用配体竞争饱和热点法(SILCS-Hotspots)进行变构配体设计的片段结合位点的鉴定和特征描述。
Biochim Biophys Acta Gen Subj. 2020 Apr;1864(4):129519. doi: 10.1016/j.bbagen.2020.129519. Epub 2020 Jan 3.
8
Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design.基于片段的药物设计中通过配体竞争饱和进行位点识别(SILCS)模拟
Methods Mol Biol. 2015;1289:75-87. doi: 10.1007/978-1-4939-2486-8_7.
9
Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design.配体竞争饱和法在计算机辅助药物设计中的应用。
New J Chem. 2022 Jan 21;46(3):919-932. doi: 10.1039/d1nj04028f. Epub 2021 Nov 29.
10
SILCS-RNA: Toward a Structure-Based Drug Design Approach for Targeting RNAs with Small Molecules.SILCS-RNA:小分子靶向 RNA 的基于结构的药物设计方法。
J Chem Theory Comput. 2022 Sep 13;18(9):5672-5691. doi: 10.1021/acs.jctc.2c00381. Epub 2022 Aug 1.

引用本文的文献

1
Detection of Putative Ligand Dissociation Pathways in Proteins Using Site-Identification by Ligand Competitive Saturation.利用配体竞争饱和法进行位点鉴定来检测蛋白质中假定的配体解离途径
J Chem Inf Model. 2025 Mar 24;65(6):3022-3034. doi: 10.1021/acs.jcim.4c01814. Epub 2024 Dec 27.
2
Modeling Ligand Binding Site Water Networks with Site Identification by Ligand Competitive Saturation: Impact on Ligand Binding Orientations and Relative Binding Affinities.利用配体竞争饱和进行位点识别来构建配体结合位点水网络:对配体结合取向和相对结合亲和力的影响
J Chem Theory Comput. 2024 Dec 24;20(24):11032-11048. doi: 10.1021/acs.jctc.4c01165. Epub 2024 Dec 5.
3
Enhancing SILCS-MC via GPU Acceleration and Ligand Conformational Optimization with Genetic and Parallel Tempering Algorithms.通过 GPU 加速和遗传并行温度算法对 SILCS-MC 进行配体构象优化。
J Phys Chem B. 2024 Aug 1;128(30):7362-7375. doi: 10.1021/acs.jpcb.4c03045. Epub 2024 Jul 20.
4
Preventing lipophilic aggregation in cosolvent molecular dynamics simulations with hydrophobic probes using Plumed Automatic Restraining Tool (PART).使用Plumed自动约束工具(PART)在含共溶剂的分子动力学模拟中,通过疏水探针防止亲脂性聚集。
J Cheminform. 2024 Feb 27;16(1):23. doi: 10.1186/s13321-024-00819-y.
5
Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy.硝基苄叉氧吗啡酮,一种具有高μ阿片受体效能的双功能μ和δ阿片受体配体。
Front Pharmacol. 2023 Jul 3;14:1230053. doi: 10.3389/fphar.2023.1230053. eCollection 2023.
6
Integrated Covalent Drug Design Workflow Using Site Identification by Ligand Competitive Saturation.基于配体竞争饱和的靶标鉴定的整合共价药物设计工作流程。
J Chem Theory Comput. 2023 May 23;19(10):3007-3021. doi: 10.1021/acs.jctc.3c00232. Epub 2023 Apr 28.
7
Site Identification by Ligand Competitive Saturation-Biologics Approach for Structure-Based Protein Charge Prediction.基于配体竞争饱和的生物大分子方法进行基于结构的蛋白电荷预测的位点鉴定。
Mol Pharm. 2023 May 1;20(5):2600-2611. doi: 10.1021/acs.molpharmaceut.3c00064. Epub 2023 Apr 5.
8
hERG Blockade Prediction by Combining Site Identification by Ligand Competitive Saturation and Physicochemical Properties.通过结合配体竞争饱和法进行位点鉴定与理化性质预测人醚 - 去极化激活的钾离子通道阻断作用
Chemistry (Basel). 2022 Sep;4(3):630-646. doi: 10.3390/chemistry4030045. Epub 2022 Jun 21.
9
Computer-Aided Drug Design: An Update.计算机辅助药物设计:更新。
Methods Mol Biol. 2023;2601:123-152. doi: 10.1007/978-1-0716-2855-3_7.
10
FTMove: A Web Server for Detection and Analysis of Cryptic and Allosteric Binding Sites by Mapping Multiple Protein Structures.FTMove:通过映射多个蛋白质结构来检测和分析隐秘和变构结合位点的网络服务器。
J Mol Biol. 2022 Jun 15;434(11):167587. doi: 10.1016/j.jmb.2022.167587. Epub 2022 Apr 18.

本文引用的文献

1
All-atom empirical potential for molecular modeling and dynamics studies of proteins.蛋白质分子建模和动力学研究的全原子经验势。
J Phys Chem B. 1998 Apr 30;102(18):3586-616. doi: 10.1021/jp973084f.
2
Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach.通过配体竞争饱和(SILCS)方法在位点识别中纳入多种片段类型。
J Chem Inf Model. 2013 Dec 23;53(12):3384-98. doi: 10.1021/ci4005628. Epub 2013 Nov 25.
3
The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.新型 BH3 α-螺旋模拟物 JY-1-106 通过破坏 Bak 与 Bcl-xL 和 Mcl-1 蛋白-蛋白相互作用,诱导一部分癌细胞(肺癌、结肠癌和间皮瘤)发生凋亡。
Mol Cancer. 2013 May 16;12(1):42. doi: 10.1186/1476-4598-12-42.
4
Approaches to efficiently estimate solvation and explicit water energetics in ligand binding: the use of WaterMap.有效估计配体结合中溶剂化和显式水能量学的方法:WaterMap 的使用。
Expert Opin Drug Discov. 2013 Mar;8(3):277-87. doi: 10.1517/17460441.2013.749853. Epub 2013 Jan 4.
5
GRID-based three-dimensional pharmacophores I: FLAPpharm, a novel approach for pharmacophore elucidation.基于网格的三维药效团 I:FLAPpharm,一种新的药效团解析方法。
J Chem Inf Model. 2012 Oct 22;52(10):2587-98. doi: 10.1021/ci300153d. Epub 2012 Sep 21.
6
Accounting for water molecules in drug design.考虑水分子在药物设计中的作用。
Expert Opin Drug Discov. 2011 Jan;6(1):65-74. doi: 10.1517/17460441.2011.534452. Epub 2010 Nov 23.
7
Balancing target flexibility and target denaturation in computational fragment-based inhibitor discovery.在基于片段的计算抑制剂发现中平衡靶标灵活性和靶标变性。
J Comput Chem. 2012 Sep 5;33(23):1880-91. doi: 10.1002/jcc.23026. Epub 2012 May 28.
8
Protein pharmacophore selection using hydration-site analysis.利用水合位点分析进行蛋白药效基团选择。
J Chem Inf Model. 2012 Apr 23;52(4):1046-60. doi: 10.1021/ci200620h. Epub 2012 Mar 26.
9
Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations.利用配体竞争饱和的位点鉴定(SILCS)模拟重现配体官能团的晶体结合模式。
J Chem Inf Model. 2011 Apr 25;51(4):877-96. doi: 10.1021/ci100462t. Epub 2011 Apr 1.
10
Ligand binding to protein-binding pockets with wet and dry regions.配体与具有湿区和干区的蛋白结合口袋结合。
Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1326-30. doi: 10.1073/pnas.1016793108. Epub 2011 Jan 4.

基于配体竞争饱和的位点识别(SILCS)辅助药效团建模。

Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling.

作者信息

Yu Wenbo, Lakkaraju Sirish Kaushik, Raman E Prabhu, MacKerell Alexander D

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD, 21201, USA.

出版信息

J Comput Aided Mol Des. 2014 May;28(5):491-507. doi: 10.1007/s10822-014-9728-0. Epub 2014 Mar 8.

DOI:10.1007/s10822-014-9728-0
PMID:24610239
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4048638/
Abstract

Database screening using receptor-based pharmacophores is a computer-aided drug design technique that uses the structure of the target molecule (i.e. protein) to identify novel ligands that may bind to the target. Typically receptor-based pharmacophore modeling methods only consider a single or limited number of receptor conformations and map out the favorable binding patterns in vacuum or with a limited representation of the aqueous solvent environment, such that they may suffer from neglect of protein flexibility and desolvation effects. Site-Identification by Ligand Competitive Saturation (SILCS) is an approach that takes into account these, as well as other, properties to determine 3-dimensional maps of the functional group-binding patterns on a target receptor (i.e. FragMaps). In this study, a method to use the FragMaps to automatically generate receptor-based pharmacophore models is presented. It converts the FragMaps into SILCS pharmacophore features including aromatic, aliphatic, hydrogen-bond donor and acceptor chemical functionalities. The method generates multiple pharmacophore hypotheses that are then quantitatively ranked using SILCS grid free energies. The pharmacophore model generation protocol is validated using three different protein targets, including using the resulting models in virtual screening. Improved performance and efficiency of the SILCS derived pharmacophore models as compared to published docking studies, as well as a recently developed receptor-based pharmacophore modeling method is shown, indicating the potential utility of the approach in rational drug design.

摘要

使用基于受体的药效团进行数据库筛选是一种计算机辅助药物设计技术,该技术利用靶分子(即蛋白质)的结构来识别可能与靶标结合的新型配体。通常,基于受体的药效团建模方法仅考虑单个或有限数量的受体构象,并在真空或有限的水性溶剂环境表示下描绘出有利的结合模式,因此它们可能会忽略蛋白质的灵活性和去溶剂化效应。通过配体竞争饱和进行位点识别(SILCS)是一种考虑到这些以及其他特性来确定靶标受体(即片段图谱)上官能团结合模式的三维图谱的方法。在本研究中,提出了一种使用片段图谱自动生成基于受体的药效团模型的方法。它将片段图谱转换为SILCS药效团特征,包括芳香、脂肪族、氢键供体和受体化学官能团。该方法生成多个药效团假设,然后使用SILCS无网格自由能进行定量排序。使用三个不同的蛋白质靶标对药效团模型生成协议进行了验证,包括在虚拟筛选中使用所得模型。结果表明,与已发表的对接研究以及最近开发的基于受体的药效团建模方法相比,SILCS衍生的药效团模型具有更高的性能和效率,表明该方法在合理药物设计中的潜在实用性。